Targeting Peptides in Radiopharmaceutical Development

Targeting peptides are designed to support selective recognition, delivery, or binding in advanced research workflows. In radiopharmaceutical development, peptide sequence, linker design, labeling strategy, and analytical verification are important parts of project planning.

Quantai can discuss synthesis feasibility, modifications, conjugation strategy, purification, and documentation needs based on the buyer's target sequence and intended research use.